Malignant rhabdoid tumor (MRT) is defined as a high-grade sarcoma derived from an uncertain cell of origin. Its diagnosis is associated with poor prognosis and patient’s life expectancy is greatly reduced.
Material and method
Here, we describe a unique case of 9-month-old boy who presented with a large MRT arising from the soft tissue of the neck. Following intensive multimodal treatment, the patient benefited from a 25 years’ remission until the discovery of multiple liver metastases.
Conclusion
MRT of soft tissue needs to be distinguished from other soft tissue neoplasms, as MRT is highly aggressive and is usually associated with a poor outcome. In addition, this is the longest remission time reported in a patient with soft tissue MRT and this might be related to the use of early intensive multimodal treatments.
BeckwithJBPalmerNF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms’ Tumor Study. Cancer1978; 41(5): 1937–1948.
2.
SultanIQaddoumiIRodríguez-GalindoCNassanAAGhandourKAl-HussainiM. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer2010; 54(1): 35–40.
EatonKWTookeLSWainwrightLM. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer2011; 56(1): 7–15.
5.
HollmannTJHornickJL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol2011; 35(10): e47–e63.
6.
SigaukeERakhejaDMaddoxDL. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol2006; 19(5): 717–725.
7.
RobertsCWBiegelJA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther2009; 8(5): 412–416.
8.
BiegelJAZhouJYRorkeLBStenstromCWainwrightLMFogelgrenB. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res1999; 59(1): 74–79.
9.
BourdeautFLequinDBrugièresL. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res2011; 17(1): 31–38.
10.
KordesUBartelheimKModenaP. Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS). Pediatr Blood Cancer2014; 61(5): 919–921.
BiegelJABusseTMWeissmanBE. SWI/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet2014; 166C(3): 350–366.
13.
BeneschMBartelheimKFleischhackG. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry(EU-RHAB). Bone Marrow Transplant2014; 49(3): 370–375.
KreigerPAJudkinsARRussoPA. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Mod Pathol2009; 22(1): 142–150.
16.
HeenanPJQuirkCJPapadimitriouJM. Epithelioid sarcoma. A diagnostic problem. Am J Dermatopathol1986; 8(2): 95–104.
17.
GleasonBCFletcherCD. Myoepithelial carcinoma of the soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol2007; 31(12): 1813–1824.
18.
LaskinWBWeissSWBratthauerGL. Epithelioid variant of malignant peripheral nerve sheath tumor (malignant epithelioid schwannoma). Am J Surg Pathol1991; 15(12): 1136–1145.
19.
FabreAEydenBAliHH. Soft-tissue extrarenal rhabdoid tumor with a unique long-term survival. Ultrastruct Pathol2004; 28(1): 49–52.
20.
Takahashi-FujigasakiJMatumotoMKanIOkaHYasueM. Atypical teratoid/rhabdoid tumor with 26-year old overall survival: case report. J Neurosurg Pediatr2012; 9: 400–405.
